ELND005 News
Most Popular ELND005 Story
Deaths force researchers to drop Alzheimer's drug doses
The deaths of nine patients in a mid-stage trial of an experimental Alzheimer's therapy being studied by Elan and Transition Therapeutics have prompted researchers to drop the two highest doses being Read more...
Latest Headlines
- December 15, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
